Folliculin (FLCN), a negative regulator of TFEB and TFE3 and an activator of mTORC1 due to its GAP activity towards RagC/D, was suggested as one of the beneficial molecular targets in NAFLD/NASH. The gene discussed is FLCN; the disease is metabolic dysfunction-associated steatohepatitis.